
Chemical Name : VX-770/VX770
CAS : 873054-44-5
Synonyms: N-[2,4-Bis(tert-butyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxo-3-quinolinecarboxamide
Solubility:DMSO
Storage:at -20℃ 2 years
Biologieal
VX-770 is a CFTR potentiator with an IC50 of 43 ± 38 nM. In recombinant cells VX-770 increased CFTR channel open probability (P(o)) in both the F508del processing mutation and the G551D gating mutation. VX-770 also increased Cl(-) secretion in cultured human CF bronchial epithelia (HBE) carrying the G551D gating mutation on one allele and the F508del processing mutation on the other allele by approximately 10-fold, to approximately 50% of that observed in HBE isolated from individuals without CF. Furthermore, VX-770 reduced excessive Na(+) and fluid absorption to prevent dehydration of the apical surface and increased cilia beating in these epithelial cultures.
Reference
[1] Van Goor F et al. Proc Natl Acad Sci U S A. 2009 Nov 3;106(44):18825-30
MK-5172/MK5172
1206524-85-7
4,6-Dichloro-1-(1,4-dioxaspiro[4.5]dec-8-yl)-1H-pyrazolo[3,4-d]pyrimidine/
Tipifarnib(R115777)/zarnestra,IND 58359
192185-72-1
KRN 951 /TIVOZANIB/AV-951
475108-18-0